This website is no longer being updated. For the latest updates on COVID-19, including vaccines and treatments, please visit www.cdc.gov/coronavirus. Healthcare professionals, please visit www.phe.gov/emergency/events/COVID19/Pages/default.aspx and www.covid19treatmentguidelines.nih.gov.
TOOLS FOR YOUR PRACTICE
THE ROLE OF MONOCLONAL ANTIBODY TREATMENT
Dr. Rachel Levine, Assistant Secretary for Health, discusses how clinicians should counsel their patients on monoclonal antibody treatment for COVID-19.
Early intervention with monoclonal antibody treatment may reduce the risk of severe illness and hospitalization for people with COVID-19 who are at high risk of developing more serious illness. This webpage includes resources that can help you ensure rapid access to monoclonal antibody treatment for your high-risk COVID-19 patients.
Is your healthcare practice interested in being a study site for an ACTIV clinical trial? Please email [email protected] with the email subject, “Potential Site for ACTIV Trials."
SUPPORT TOOLS FOR CLINICIANS
TOOLS FOR YOUR PRACTICE
Identification and Referral
Download a brief guide to identifying and referring high-risk patients.
Find a one-stop resource for guidance and instructions on preparing your facility, administering mAb treatments, and reporting therapeutic data and adverse events.
Billing and Reimbursement
Learn about Medicaid, Medicare, and commercial insurance coverage for mAb treatment.
Download a script you can use to inform patients they have tested positive for COVID-19.
HELP YOUR PATIENTS UNDERSTAND mAb TREATMENTS
Read a Frequently Asked Questions (FAQ) document to help answer patient questions.
Download "An Option for COVID-19 Positive Patients: Monoclonal Antibody Treatment" to help your patients understand how mAb treatment can help prevent more serious COVID-19 illness.
Download an informational poster for your practice.
CLINICAL EVIDENCE, GUIDELINES, AND VIDEOS
Clinical Evidence Summary
Read a summary of the clinical evidence and Emergency Use Authorizations (EUAs) for monoclonal antibodies.
Read a provider FAQs document about the science behind mAbs for COVID-19.
Browse up-to-date resources for healthcare providers, including the April 2021 National Institutes of Health COVID-19 treatment guidelines, Centers for Disease Control and Prevention data on variants by state, EUA fact sheets, and more.
Hear from leading experts and watch a series on how to set up and manage infusion operations in your facility—from patient flow to safety to training.
COVID-19 CLINICAL TRIAL OPPORTUNITIES FOR YOUR PATIENTS
Find clinical trials for four patient categories: 1) patients with COVID-19 who are not in the hospital; 2) patients with COVID-19 who are in the hospital; 3) adults who have been exposed to COVID-19 but have not developed symptoms; and 4) adult patients who have been discharged from the hospital.
The following documents describe promising practices and recommendations from provider organizations and states that have increased the use of mAb treatments for COVID-19. These findings may help those who working to build treatment awareness and demand. They can also supplement individual plans and provide context to playbooks and planning discussions with leadership.
FDA PROVIDER FACT SHEETS
Learn more about the products the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to help Combat COVID-19.
PEER REVIEWED ARTICLES
Explore the following peer-reviewed articles that discuss a range of COVID-19 treatment topics.
Monoclonal Antibody Treatment Locator
Use this tool to find out if you or a loved one may qualify for monoclonal antibody (mAb) treatment and, if you do qualify, how you can get mAb treatment. If you’re high risk, talk to your healthcare provider about mAb treatment.